Literature DB >> 16581343

Herbs or natural substances as complementary therapies for chronic kidney disease: ideas for future studies.

Ken Wojcikowski1, David W Johnson, Glenda Gobe.   

Abstract

Chronic kidney disease (CKD) is an increasingly common condition with limited treatment options that is placing a major financial and emotional burden on the community. The use of complementary and alternative medicines (CAMS) has increased many-fold over the past decade. Although several compelling studies show renal toxicities and an adverse outcome from use of some CAMS, there is also emerging evidence in the literature that some may be renoprotective. Many nephrologists are unaware of these potential therapeutic benefits in treating CKD, or they are reluctant to consider them in research trials for fear of adverse effects (including nephrotoxicity) or deleterious interaction with co-prescribed, conventional medicines. The increased use of self-prescribed CAMS by their patients suggests that practitioners and researchers should keep abreast of the current information on these agents. A primary goal of this article was to review the available scientific evidence for the use of herbs or natural substances as a complementary treatment for patients with CKD. A further goal was to report the literature on herbs that have been reported to cause kidney failure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16581343     DOI: 10.1016/j.lab.2005.11.011

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  31 in total

1.  Identification of cryptotanshinone as an inhibitor of oncogenic protein tyrosine phosphatase SHP2 (PTPN11).

Authors:  Wei Liu; Bing Yu; Gang Xu; Wei-Ren Xu; Mignon L Loh; Li-Da Tang; Cheng-Kui Qu
Journal:  J Med Chem       Date:  2013-09-04       Impact factor: 7.446

2.  Cryptotanshinone inhibits lymphatic endothelial cell tube formation by suppressing VEGFR-3/ERK and small GTPase pathways.

Authors:  Yan Luo; Wenxing Chen; Hongyu Zhou; Lei Liu; Tao Shen; J Steven Alexander; Shizhong Zheng; Yin Lu; Shile Huang
Journal:  Cancer Prev Res (Phila)       Date:  2011-08-31

3.  Cryptotanshinone inhibits cancer cell proliferation by suppressing Mammalian target of rapamycin-mediated cyclin D1 expression and Rb phosphorylation.

Authors:  Wenxing Chen; Yan Luo; Lei Liu; Hongyu Zhou; Baoshan Xu; Xiuzhen Han; Tao Shen; Zhijun Liu; Yin Lu; Shile Huang
Journal:  Cancer Prev Res (Phila)       Date:  2010-07-13

Review 4.  Nutritional and therapeutic perspectives of Chia (Salvia hispanica L.): a review.

Authors:  Rahman Ullah; M Nadeem; A Khalique; M Imran; S Mehmood; A Javid; J Hussain
Journal:  J Food Sci Technol       Date:  2015-10-01       Impact factor: 2.701

5.  Cordyceps cicadae extracts ameliorate renal malfunction in a remnant kidney model.

Authors:  Rong Zhu; Yi-ping Chen; Yue-yi Deng; Rong Zheng; Yi-fei Zhong; Lin Wang; Lan-ping Du
Journal:  J Zhejiang Univ Sci B       Date:  2011-12       Impact factor: 3.066

6.  Cryptotanshinone activates p38/JNK and inhibits Erk1/2 leading to caspase-independent cell death in tumor cells.

Authors:  Wenxing Chen; Lei Liu; Yan Luo; Yoshinobu Odaka; Sanket Awate; Hongyu Zhou; Tao Shen; Shizhong Zheng; Yin Lu; Shile Huang
Journal:  Cancer Prev Res (Phila)       Date:  2012-04-03

7.  Inhibition of adriamycin-induced nephropathy in rats by herbs based kangshenoral solution.

Authors:  Jingsheng Zhao; Xinwei Lin; Xueqing Xiao; Jun Yang; Hong Liu; Weiguo Yi; Zhengchen Zhang; Xinkuan Zhang
Journal:  Int J Clin Exp Med       Date:  2015-12-15

8.  Association of prescribed Chinese herbal medicine use with risk of end-stage renal disease in patients with chronic kidney disease.

Authors:  Ming-Yen Lin; Yi-Wen Chiu; Jung-San Chang; Hung-Lung Lin; Charles Tzu-Chi Lee; Guei-Fen Chiu; Mei-Chuan Kuo; Ming-Tsang Wu; Hung-Chun Chen; Shang-Jyh Hwang
Journal:  Kidney Int       Date:  2015-08-05       Impact factor: 10.612

9.  Yi-Qi-Jian-Pi-Xiao-Yu-Xie-Zhuo Formula Improves Muscle Atrophy via Modulating the IGF-1/PI3K/Akt Signaling Pathway in 5/6 Nephrectomized Rats.

Authors:  Hong Xia; Bingbing Zhang; Dan Yang; Chengyue Zhu; Jiudan Zhang; Hongbo Chen; Hongzhen Ma; Shouci Hu; Chao Xu; Chengqian Shi; Keda Lu; Peipei Zhang
Journal:  Front Pharmacol       Date:  2021-04-27       Impact factor: 5.810

10.  Herbal Medicine "Shulifenxiao" Formula for Nephrotic Syndrome of Refractory Idiopathic Membranous Nephropathy.

Authors:  Hailan Cui; Frank Qiang Fu; Baoli Liu; Wei Jing Liu; Yu Ning Liu
Journal:  Front Pharmacol       Date:  2021-05-10       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.